Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12613000495729
Ethics application status
Approved
Date submitted
22/04/2013
Date registered
3/05/2013
Date last updated
3/05/2013
Type of registration
Retrospectively registered
Titles & IDs
Public title
Dexmeditomedine for mitral valve replacement
Query!
Scientific title
dexmeditomedine for heart rate control during mitral valve replacement for mitral stenosis a randomised controlled double blind study
Query!
Secondary ID [1]
282384
0
nil known
Query!
Universal Trial Number (UTN)
nil
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
patients with tight mitral stenosis scheduled for mitral valve replacement
288965
0
Query!
Condition category
Condition code
Anaesthesiology
289299
289299
0
0
Query!
Anaesthetics
Query!
Cardiovascular
289300
289300
0
0
Query!
Other cardiovascular diseases
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
70 patients scheduled for mitral valve replacement divided equally into two groups were studied in this randomized controlled double blind study ; Group D : received (after induction of anesthesia) dexmeditomedine 1ug/kg bolus dose over 10 minutes followed by an infusion of 0.5 ug/kg/h till the start of cardiopulmonary bypass. Group F: received saline bolus ( after induction of anesthesia ) and infusion of saline till the start of cardiopulmonary bypass instead of dexmeditomedine .Anesthetic management for both groups was the same.
Query!
Intervention code [1]
287014
0
Treatment: Drugs
Query!
Intervention code [2]
287015
0
Prevention
Query!
Comparator / control treatment
we compared the effect of dexmeditomedine bolus and infusion on the heart rate of patients with tight mitral stenosis compared to placebo
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
289407
0
heart rate changes as measured by pulse oximeter and ECG
Query!
Assessment method [1]
289407
0
Query!
Timepoint [1]
289407
0
the start of infusion following a bolus of dexmeditomedine after induction of anesthesia and every 10 minutes after the end of the bolus till the start of cardiopulmonary bypass
Query!
Secondary outcome [1]
302534
0
nil
Query!
Assessment method [1]
302534
0
Query!
Timepoint [1]
302534
0
none
Query!
Eligibility
Key inclusion criteria
patients ASAI&II with tight ( less than one centimeter ) mitral stenosis aged 18-60 years of age scheduled for mitral valve replacement
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
60
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
age above or below 18-60 years , mitral valve area more than one centimeter, renal or hepatic dysfunction , cardiac medications that affect heart rate
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
it is a computer generated allocation using graphpad software
allocation was concealed using sealed envelopes
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
we used a computer generated sequence
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
The Graph Pad Instat 3.0 was used to estimate sample size of 33 cases for each group (completed to 35 cases) to be sufficient for 80 % power to detect a difference of 20 % in heart rate( a difference 0f 13.6 in mean heart rate between the two groups ) and mean blood pressure (based on previously published data) under a 5% significance level ( graphPad software, San Deigo , CA, USA.)). Chi-square test was used for analysis of non-parametric data between the two groups and Mc-Nemar test for analysis within each group. Unpaired –t - test was used for analysis of parametric data between the two groups ,while paired-t-test test was used for analysis of parametric data within each group, data are expressed as mean+/- SD and P value less than 0.05 was considered statistically significant.
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
5/11/2011
Query!
Actual
5/11/2011
Query!
Date of last participant enrolment
Anticipated
2/05/2013
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
70
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
5040
0
Egypt
Query!
State/province [1]
5040
0
Qena - upper Egypt
Query!
Funding & Sponsors
Funding source category [1]
287157
0
University
Query!
Name [1]
287157
0
south valley university - Egypt
Query!
Address [1]
287157
0
Egypt - Qena - South valley university - Qena faculty of medicine P.O. 6111 -Qena
Query!
Country [1]
287157
0
Egypt
Query!
Primary sponsor type
Hospital
Query!
Name
south valley university -Qena university hospital
Query!
Address
Qena university hospital -Qena - P.O. 61111- Qena
Query!
Country
Egypt
Query!
Secondary sponsor category [1]
285953
0
None
Query!
Name [1]
285953
0
Query!
Address [1]
285953
0
Query!
Country [1]
285953
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Summary
Brief summary
testing the efficacy and safety of dexmeditomedine in controlling heart rate in patients with tight mitral stenosis subjected to mitral valve replacement during the prebypass period
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
39498
0
A/Prof salah mostafa asida
Query!
Address
39498
0
South Valley University -Qena faculty of medicine - department of anesthesia - P.O. 61111- Qena- Egypt
Query!
Country
39498
0
Egypt
Query!
Phone
39498
0
+201005262075
Query!
Fax
39498
0
Query!
Email
39498
0
[email protected]
Query!
Contact person for public queries
Name
39499
0
salah asida
Query!
Address
39499
0
South Valley University - Qena faculty of medicine - department of anesthesia - P.O. 61111- Qena Egypt
Query!
Country
39499
0
Egypt
Query!
Phone
39499
0
+201005262075
Query!
Fax
39499
0
Query!
Email
39499
0
[email protected]
Query!
Contact person for scientific queries
Name
39500
0
salah asida
Query!
Address
39500
0
South Valley University- Qena faculty of medicine - department of anesthesia - P.O. 61111- Qena- Egypt
Query!
Country
39500
0
Egypt
Query!
Phone
39500
0
+201005262075
Query!
Fax
39500
0
Query!
Email
39500
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF